This c-MYC-dependent triggering of intron retention presumably compels the Sestrin-1 and SRPX2 genes to undergo a similar process of noncanonical splicing (Figure 3 and Figure 5), likely providing melanoma cells with certain survival, growth, and motility advantages. The gene discussed is MYC; the disease is melanoma.